FDA Approved: SOLIRIS — Supplemental Application (Alexion Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SOLIRIS (eculizumab) filed by Alexion Pharmaceuticals, resulting in updated labeling that may include new or exp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome
• Myasthenia Gravis
• Neuromyelitis Optica Spectrum Disorder
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

SUPPL AP for SOLIRIS (ECULIZUMAB)